Cited 0 times in
Seroprevalence of severe acute respiratory syndrome coronavirus 2 antibodies during the third wave of coronavirus disease in the Seoul metropolitan area of Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이혁민 | - |
dc.date.accessioned | 2023-04-07T01:14:54Z | - |
dc.date.available | 2023-04-07T01:14:54Z | - |
dc.date.issued | 2022-09 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/193842 | - |
dc.description.abstract | Objectives: After the third wave of coronavirus disease (COVID-19), by mid-February 2021, approximately 0.16% of the population was confirmed positive, which appeared to be one of the lowest rates worldwide at that time. However, asymptomatic transmission poses a challenge for COVID-19 surveillance. Therefore, a community-based serosurvey of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was conducted to understand the effectiveness of Korea's strong containment strategy. Methods: We collected 5,002 residual sera samples from January 30 to March 3, 2021 from 265 medical facilities in Seoul, 346 in Kyunggi-do' and 57 in Incheon. Among them, 60 samples from tertiary institutions were excluded. We defined the sub-regions according to the addresses of the medical facilities where the specimens were collected. Elecsys Anti-SARS-CoV-2 was used for the screening test, and positivity was confirmed using the SARS-CoV-2 sVNT Kit. Prevalence was estimated using sampling weight and the Wilson score interval for a binomial proportion with a 95% confidence interval. Results: Among the 4,942 specimens, 32 and 25 tested positive for COVID-19 in the screening and confirmatory tests, respectively. The overall crude prevalence of SARS-CoV-2 antibody was 0.51%. The population-adjusted overall prevalence was 0.55% in women and 0.38% in men. The region-specific estimation was 0.67% and 0.30% in Gyeonggi-do and Seoul, respectively. No positive cases were detected in Incheon. Conclusion: The proportion of undetected cases in South Korea remains low. Therefore, an infection control strategy with exhaustive tracing and widespread pre-emptive testing appears to be effective in containing the spread of the virus in the community. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Korean Society of Epidemiology | - |
dc.relation.isPartOf | EPIDEMIOLOGY AND HEALTH | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Seroprevalence of severe acute respiratory syndrome coronavirus 2 antibodies during the third wave of coronavirus disease in the Seoul metropolitan area of Korea | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Laboratory Medicine (진단검사의학교실) | - |
dc.contributor.googleauthor | Kyuhyun Yoon | - |
dc.contributor.googleauthor | Jayeun Kim | - |
dc.contributor.googleauthor | Kyong Ran Peck | - |
dc.contributor.googleauthor | Hyun Soo Kim | - |
dc.contributor.googleauthor | Hyukmin Lee | - |
dc.contributor.googleauthor | Yoo-Sung Hwang | - |
dc.contributor.googleauthor | Soon Young Lee | - |
dc.contributor.googleauthor | Sung-Il Cho | - |
dc.contributor.googleauthor | Hun Jae Lee | - |
dc.contributor.googleauthor | Yeongyeong Kim | - |
dc.contributor.googleauthor | Brian Byoungguk Kim | - |
dc.contributor.googleauthor | June-Woo Lee | - |
dc.contributor.googleauthor | Ah-Ra Kim | - |
dc.contributor.googleauthor | HyeonNam Do | - |
dc.contributor.googleauthor | Dong-Hyun Kim | - |
dc.identifier.doi | 10.4178/epih.e2022085 | - |
dc.contributor.localId | A03286 | - |
dc.relation.journalcode | J00791 | - |
dc.identifier.eissn | 2092-7193 | - |
dc.identifier.pmid | 36228670 | - |
dc.subject.keyword | Asymptomatic | - |
dc.subject.keyword | Coronavirus disease | - |
dc.subject.keyword | Cumulative incidence | - |
dc.subject.keyword | Seroprevalence | - |
dc.subject.keyword | Severe acute respiratory syndrome coronavirus 2 | - |
dc.contributor.alternativeName | Lee, Hyuk Min | - |
dc.contributor.affiliatedAuthor | 이혁민 | - |
dc.citation.volume | 44 | - |
dc.citation.startPage | e2022085 | - |
dc.identifier.bibliographicCitation | EPIDEMIOLOGY AND HEALTH, Vol.44 : e2022085, 2022-09 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.